|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
|
US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
|
JP5138938B2
(ja)
|
2003-12-19 |
2013-02-06 |
プレキシコン インコーポレーテッド |
Ｒｅｔ調節剤の開発のための化合物および方法
|
|
ES2364340T3
(es)
*
|
2004-03-30 |
2011-08-31 |
Vertex Pharmaceuticals Incorporated |
Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
US7452993B2
(en)
|
2004-07-27 |
2008-11-18 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US7626021B2
(en)
*
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US7709645B2
(en)
*
|
2004-07-27 |
2010-05-04 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
NZ553267A
(en)
|
2004-07-27 |
2010-09-30 |
Sgx Pharmaceuticals Inc |
Pyrrolo-pyridine kinase modulators
|
|
US7361764B2
(en)
|
2004-07-27 |
2008-04-22 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
EP1828180A4
(en)
*
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
|
CN101193862B
(zh)
|
2005-04-13 |
2013-08-21 |
阿斯特克斯治疗有限公司 |
羟基苯甲酰胺衍生物和其作为hsp90抑制剂的用途
|
|
AU2006272951A1
(en)
*
|
2005-05-17 |
2007-02-01 |
Plexxikon, Inc. |
Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
NZ592968A
(en)
|
2006-01-17 |
2012-08-31 |
Vertex Pharma |
Azaindoles substituted with either triazine or pyrimidine useful as inhibitors of janus kinases consisting of JAK1, JAK2, JAK3, and TYK2
|
|
US7754725B2
(en)
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
|
DE102006012617A1
(de)
*
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
US8604031B2
(en)
*
|
2006-05-18 |
2013-12-10 |
Mannkind Corporation |
Intracellular kinase inhibitors
|
|
US20070286864A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Buck Elizabeth A |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
US20080242694A1
(en)
*
|
2006-09-18 |
2008-10-02 |
D Sidocky Neil R |
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
|
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
JP5721949B2
(ja)
|
2006-10-12 |
2015-05-20 |
アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ |
複合薬剤
|
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8883790B2
(en)
|
2006-10-12 |
2014-11-11 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
JP5518478B2
(ja)
|
2006-10-12 |
2014-06-11 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
KR20090082453A
(ko)
*
|
2006-11-01 |
2009-07-30 |
버텍스 파마슈티칼스 인코포레이티드 |
야누스 키나제의 억제제로서 유용한 트리사이클릭 헤테로아릴 화합물
|
|
JP5244118B2
(ja)
*
|
2006-11-10 |
2013-07-24 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規キナーゼ阻害剤
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
GEP20125658B
(en)
|
2006-11-22 |
2012-10-10 |
Incyte Corp |
Imidazotriazines and imidazo pyrimidines as kinase inhibitors
|
|
PE20121126A1
(es)
*
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
|
RU2009122670A
(ru)
*
|
2006-12-21 |
2011-01-27 |
Плекссикон, Инк. (Us) |
Соединения и способы для модуляции киназ и показания к их применению
|
|
WO2008079346A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
EP2121613A2
(en)
*
|
2007-01-31 |
2009-11-25 |
Vertex Pharmaceuticals, Inc. |
2-aminopyridine derivatives useful as kinase inhibitors
|
|
GB0702265D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-Azaindole derivatives
|
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
WO2008124848A1
(en)
|
2007-04-10 |
2008-10-16 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US8263585B2
(en)
*
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
US20090156594A1
(en)
*
|
2007-05-21 |
2009-06-18 |
Sgx Pharmaceuticals, Inc. |
Heterocyclic kinase modulators
|
|
DE102007028515A1
(de)
*
|
2007-06-21 |
2008-12-24 |
Merck Patent Gmbh |
6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
WO2009009042A1
(en)
*
|
2007-07-06 |
2009-01-15 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing substituted tetracycline compounds
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン，インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
MX2010001020A
(es)
*
|
2007-07-26 |
2010-03-01 |
Novartis Ag |
Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
|
|
JP2011500806A
(ja)
*
|
2007-10-25 |
2011-01-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
治療用化合物
|
|
US8598165B2
(en)
*
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
SI2300455T1
(sl)
|
2008-05-21 |
2017-12-29 |
Incyte Holdings Corporation |
Soli 2-fluoro-n-metil-4-(7-(kinolin-6-il-metil)-imidazo(1,2-b)1,2,4) triazin-2-il)benzamid in postopki v zvezi z njihovo pripravo
|
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
MX2011000837A
(es)
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolpiridina cinasa triciclica.
|
|
NZ590784A
(en)
|
2008-07-23 |
2012-12-21 |
Vertex Pharma |
Pyrazolopyridine kinase inhibitors
|
|
DK2308877T3
(da)
|
2008-08-05 |
2014-04-22 |
Daiichi Sankyo Co Ltd |
Imidazopyridin-2-on-derivater
|
|
MX2011001370A
(es)
*
|
2008-08-05 |
2011-03-15 |
Abbott Lab |
Compuestos utiles como inhibidores de cinasas de proteina.
|
|
MX2011001319A
(es)
|
2008-08-06 |
2011-04-05 |
Vertex Pharma |
Inhibidores de aminopiridina cinasa.
|
|
CN102264743B
(zh)
|
2008-11-25 |
2015-02-11 |
罗彻斯特大学 |
Mlk抑制剂及其使用方法
|
|
WO2010083283A2
(en)
*
|
2009-01-15 |
2010-07-22 |
Incyte Corporation |
Processes for preparing jak inhibitors and related intermediate compounds
|
|
FR2941948B1
(fr)
|
2009-02-12 |
2013-04-05 |
Nova Decision |
Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
|
|
CA2738573C
(en)
*
|
2009-04-03 |
2013-02-19 |
F. Hoffmann-La Roche Ag |
Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
|
|
WO2010129668A1
(en)
|
2009-05-06 |
2010-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
|
GEP20207129B
(en)
|
2009-06-17 |
2020-07-10 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
|
EP2266562A1
(en)
*
|
2009-06-23 |
2010-12-29 |
Centre National de la Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
|
US8703808B2
(en)
|
2009-06-23 |
2014-04-22 |
Centre National De La Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
|
GB0918924D0
(en)
*
|
2009-10-28 |
2009-12-16 |
Vantia Ltd |
Azaindole derivatives
|
|
JP2013510166A
(ja)
|
2009-11-06 |
2013-03-21 |
プレキシコン インコーポレーテッド |
キナーゼ調節のための化合物、方法およびその適用
|
|
PT3511330T
(pt)
|
2009-12-31 |
2020-12-24 |
Hutchison Medipharma Ltd |
Intermediário sintético útil na preparação de inibidores de triazolopiridina c-met
|
|
EP2528917B1
(en)
|
2010-01-27 |
2016-10-19 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines useful for the treatment of autoimmune, inflammatory or (hyper)proliferative diseases
|
|
AU2011209649A1
(en)
|
2010-01-27 |
2012-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
|
EP2582702A1
(en)
|
2010-01-27 |
2013-04-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrimidine kinase inhibitors
|
|
BR112012019120A2
(pt)
|
2010-02-03 |
2016-06-28 |
Infinity Pharmaceuticais Inc |
forma sólida, composição farmacêutica, método de preparação do composto 1, método de tratamento de uma condição mediada por faah
|
|
EP2560971B1
(en)
*
|
2010-04-19 |
2014-04-09 |
Abbvie Inc. |
Pyrrolopyridines as inhibitors of kinases
|
|
WO2011140164A1
(en)
*
|
2010-05-06 |
2011-11-10 |
Merck Sharp & Dohme Corp. |
Aza-indole derivatives useful as modulators of faah
|
|
EP2576549A4
(en)
|
2010-05-24 |
2013-12-18 |
Univ Rochester |
Bicyclic Heteroarylkinase Inhibitors and Methods of Use
|
|
US8779150B2
(en)
*
|
2010-07-21 |
2014-07-15 |
Hoffmann-La Roche Inc. |
Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
|
|
RU2013132681A
(ru)
|
2010-12-16 |
2015-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
|
PE20141360A1
(es)
|
2011-02-07 |
2014-10-13 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
|
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
|
WO2012135631A1
(en)
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
|
CA2836474A1
(en)
|
2011-05-17 |
2012-11-22 |
Plexxikon Inc. |
Kinase modulation and indications therefor
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
US9096598B2
(en)
*
|
2011-10-03 |
2015-08-04 |
Merck Sharp & Dohme Corp. |
Azaindoles as Janus kinase inhibitors
|
|
DE102011119127A1
(de)
*
|
2011-11-22 |
2013-05-23 |
Merck Patent Gmbh |
3-Cyanaryl-1H-pyrrolo[2.3-b]pyridin-Derivate
|
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
US10485800B2
(en)
|
2012-11-30 |
2019-11-26 |
The University Of Rochester |
Mixed lineage kinase inhibitors for HIV/AIDS therapies
|
|
US9260426B2
(en)
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
CN105073747B
(zh)
*
|
2013-03-15 |
2017-06-06 |
普莱希科公司 |
杂环化合物及其应用
|
|
US9206188B2
(en)
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
|
CN104119331B
(zh)
*
|
2013-04-26 |
2018-02-06 |
广东东阳光药业有限公司 |
烯基化合物及其使用方法和用途
|
|
GB2515785A
(en)
*
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
|
PT3068776T
(pt)
|
2013-11-13 |
2019-08-26 |
Vertex Pharma |
Inibidores da replicação de vírus da gripe
|
|
HUE038820T2
(hu)
|
2013-11-13 |
2018-11-28 |
Vertex Pharma |
Eljárás influenzavírusok replikációjának inhibitorai elõállítására
|
|
AU2016209046A1
(en)
*
|
2015-01-23 |
2017-07-20 |
Aclaris Therapeutics, Inc. |
Heterocyclic ITK inhibitors for treating inflammation and cancer
|
|
KR101660863B1
(ko)
*
|
2015-04-03 |
2016-09-28 |
주식회사 녹십자 |
IKKε 및 TBK1 억제제로서의 7-아자인돌 또는 4,7-다이아자인돌 유도체 및 이를 포함하는 약학적 조성물
|
|
US10160755B2
(en)
*
|
2015-04-08 |
2018-12-25 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
|
EP3383875B1
(en)
*
|
2015-11-30 |
2022-02-09 |
Council Of Scientific & Industrial Research |
3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof
|
|
US9938273B2
(en)
|
2015-12-07 |
2018-04-10 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2018217766A1
(en)
|
2017-05-22 |
2018-11-29 |
Whitehead Institute For Biomedical Research |
Kcc2 expression enhancing compounds and uses thereof
|
|
WO2018226846A1
(en)
|
2017-06-07 |
2018-12-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
|
CN107550905B
(zh)
*
|
2017-09-11 |
2020-07-17 |
浙江永宁药业股份有限公司 |
多取代吡咯并吡啶类化合物的药物用途及其制备方法
|
|
WO2019057660A1
(en)
*
|
2017-09-25 |
2019-03-28 |
Basf Se |
INDOLE AND AZAINDOLE COMPOUNDS HAVING 6-CHANNEL SUBSTITUTED ARYL AND HETEROARYL CYCLES AS AGROCHEMICAL FUNGICIDES
|
|
US10717735B2
(en)
|
2017-10-13 |
2020-07-21 |
Plexxikon Inc. |
Solid forms of a compound for modulating kinases
|
|
CA3092828A1
(en)
|
2018-03-01 |
2019-09-06 |
The Trustees Of Columbia University In The City Of New York |
Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress
|
|
TW202039483A
(zh)
*
|
2018-11-22 |
2020-11-01 |
英屬開曼群島商百濟神州有限公司 |
作為HPK1抑制劑的吡咯並[2,3-b]吡啶以及它們的用途
|
|
JP7636646B2
(ja)
*
|
2019-04-09 |
2025-02-27 |
オプナ バイオ ソシエテ アノニム |
Ｅｐ３００またはｃｂｐの調節のための縮合アジンおよびその適応
|
|
TWI848141B
(zh)
|
2019-07-04 |
2024-07-11 |
英屬開曼群島商百濟神州有限公司 |
及其用途
|
|
US12459958B2
(en)
|
2019-07-17 |
2025-11-04 |
Beone Medicines I Gmbh |
Tricyclic compounds as HPK1 inhibitor and the use thereof
|
|
US12673933B2
(en)
|
2019-08-21 |
2026-07-07 |
Beone Medicines I Gmbh |
Aminopyrazine compounds as HPK1 inhibitor and the use thereof
|
|
JP7564888B2
(ja)
|
2020-05-01 |
2024-10-09 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｄ７３阻害性２，４－ジオキソピリミジン化合物
|
|
WO2022076973A1
(en)
*
|
2020-10-05 |
2022-04-14 |
Enliven Therapeutics, Inc. |
7-azaindole compounds for inhibition of bcr-abl tyrosine kinases
|
|
JP7885250B2
(ja)
*
|
2021-05-21 |
2026-07-06 |
センター ナショナル デ ラ レシェルシェ サイエンティフィーク |
抗ウイルス剤としての新規アザインドール誘導体
|
|
WO2023023942A1
(en)
*
|
2021-08-24 |
2023-03-02 |
Biofront Ltd (Cayman) |
Hpk1 inhibitors, compositions comprising hpk1 inhibitor, and methods of using the same
|
|
WO2023245327A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multiple kinase degraders, compositions comprising the degrader, and methods of using the same
|
|
WO2023245329A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multi-kinase inhibitors, compositions thereof, and methods of using the same
|